Biology subjects

Tavella, T.

Publications and source records attributed to Tavella, T..

3 recordsLinked to original sources

bioRxiv2023

Molecular and phenotypic blueprint of the hematopoietic compartment reveals proliferation stress as a driver of age-associated human stem cell dysfunctions

Hematopoietic stem/progenitor cell (HSPC) aging studies have been associated with myeloid skewing, reduced clonal output, and impaired regenerative capacity, but quantitative immunophenotypic and functional analysis across human aging is lacking. Here, we provide a comprehensive phenotypic, transcriptional, and functional dissection of human hematopoiesis across the lifespan. Although primitive HSPC numbers were stable during aging, overall cellularity was reduced, especially for erythroid and lymphoid lineages. Notably, HSPC from aged individuals had superior repopulating frequency than younger counterparts in xenografts; yet aged HSPC displayed epigenetic dysregulation of cell cycle, inflammatory signatures, and a reduced capacity to counteract activation-induced proliferative stress with concomitant accumulation of DNA damage and senescence-like features upon xenotransplantation. This phenotype was recapitulated by enforcing proliferative stress in vivo on cord blood (CB) HSPC. Overall, our work sheds light on dysregulated responses to activation-induced proliferation underlying HSPC aging and establishes CB xenotransplantation-based models as suitable for studying age-associated hematopoietic defects.

cell biology↗

bioRxiv2022

Therapy-induced senescence upregulates antigen presentation machinery and triggers anti-tumor immunity in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is an aggressive hematological malignancy often curable only by using intensive chemotherapy. Nonetheless, resistance/early relapses are frequent, underscoring the need to investigate the molecular events occurring shortly after chemotherapy. Therapy-induced senescence (TIS) is a fail-safe tumor suppressive mechanism that may elicit immune-mediated responses contributing to senescent cell clearance. Yet, TIS functional role in AML eradication and immune surveillance early post-chemotherapy remains ill-defined. By combining transcriptional and cellular-based evaluation of senescence markers in AML patient samples, we found upregulation of senescence-associated genes and interferon gene categories with concomitant induction of HLA class I and class II molecules, pointing to a causal link between TIS and leukemia immunogenicity. Consistently, senescence-competent AML samples activated autologous CD4+ and CD8+ T cells and improved leukemia recognition by both T-cell subsets. Lastly, the anti-leukemic activity of Immune Checkpoint Blockades (ICBs) was enhanced upon senescence engagement in AML. Altogether, our results identify senescence as a potent immune-related anti-leukemic mechanism that may rapidly translate into innovative senescence-based strategies to prevent AML relapse. STATEMENT OF SIGNIFICANCEOur findings uncover a novel link between senescence induction and leukemia immune recognition by T cells via upregulation of antigen presentation machinery components, providing the basis for conceptually novel senescence-based targeted immunotherapeutic regimens for AML patients.

cancer biology↗

bioRxiv2018

Using ribosome profiling to quantify differences in protein expression: a case study in Saccharomyces cerevisiae oxidative stress conditions

Cells respond to changes in the environment by modifying the concentration of specific proteins. Paradoxically, the cellular response is usually examined by measuring variations in transcript abundance by high throughput RNA sequencing (RNA-Seq), instead of directly measuring protein concentrations. This happens because RNA-Seq-based methods provide better quantitative estimates, and more extensive gene coverage, than proteomics-based ones. However, variations in transcript abundance do not necessarily reflect changes in the corresponding protein abundance. How can we close this gap? Here we explore the use of ribosome profiling (Ribo-Seq) to perform differentially gene expression analysis in a relatively well-characterized system, oxidative stress in bakers yeast. Ribo-Seq is an RNA sequencing method that specifically targets ribosome-protected RNA fragments, and thus is expected to provide a more accurate view of changes at the protein level than classical RNA-Seq. We show that gene quantification by Ribo-Seq is indeed more highly correlated with protein abundance, as measured from mass spectrometry data, than quantification by RNA-Seq. The analysis indicates that, whereas a subset of genes involved in oxidation-reduction processes is detected by both types of data, the majority of the genes that happen to be significant in the RNA-Seq-based analysis are not significant in the Ribo-Seq analysis, suggesting that they do not result in protein level changes. The results illustrate the advantages of Ribo-Seq to make inferences about changes in protein abundance in comparison with RNA-Seq.

genomics↗